Hemispherx BioPharma (HEB)

[ryan128]

I would say 70% or better. Here is my reasoning why:

HEB does show according to the numbers they are submitting a definate quality of life improvement.

The culture at the FDA seems to have changed views on drugs for diseases on CFS/ME. Maybe because of political or not. But this can not be denied.

There is no dedicated treatment as of right now. Just off label treatment of CFS/ME.

Several CFS/ME experts and patients have reported very good results and some amazing results with Ampligen. Just like any other treatment approved or not some patients will do well and others not.

I do understand where the analysts are bashing HEB. But it is important to understand not invest solely on analyst reports. If it was that easy those analysts and columnists would be retired not writing for a living. If I solely traded off of columnists and analysts predictions I would be broke. This is why I do not pay for such services. These people would not have to make a living doing that if their opinions are spot on. They would be the richest people in the world.